We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
-18.27%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$245M
AUM Growth
+$16.7M
(+7.3%)
Cap. Flow
+$61.4M
Cap. Flow
% of AUM
25.11%
Top 10 Holdings %
Top 10 Hldgs %
8.03%
Holding
1,200
New
565
Increased
162
Reduced
81
Closed
389
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$4.49M |
| 2 |
Amgen
AMGN
|
+$2.44M |
| 3 |
Carnival Corporation Ltd
CCL
|
+$2.31M |
| 4 |
Caterpillar
CAT
|
+$1.92M |
| 5 |
PepsiCo
PEP
|
+$1.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.15M |
| 2 |
Lam Research
LRCX
|
+$1.81M |
| 3 |
Adobe
ADBE
|
+$1.76M |
| 4 |
Cisco
CSCO
|
+$1.65M |
| 5 |
Johnson & Johnson
JNJ
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.26% |
| 2 | Healthcare | 17.17% |
| 3 | Industrials | 11.48% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Financials | 11.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRNE
476
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $195K | 0.08% |
97,095
+77,843
| +404% | +$135K |
|
477
TripAdvisor
TRIP
$1.66B
| $193K | 0.08% |
+10,819
| New | +$257K |
|
478
Enovix
ENVX
$923M
| $191K | 0.08% |
+24,558
| New | +$231K |
|
479
Stem
STEM
$50M
| $190K | 0.08% |
+1,324
| New | +$220K |
|
480
AerSale
ASLE
$307M
| $189K | 0.08% |
13,009
+2,859
| +28% | +$41.5K |
|
|
BBBY
481
DELISTED
Bed Bath & Beyond Inc
BBBY
| $188K | 0.08% |
37,916
+26,169
| +223% | +$305K |
|
482
Jet.AI
JTAI
$2.77M
| – | – |
0
| – | – |
|
|
ZUO
483
DELISTED
Zuora, Inc.
ZUO
| $187K | 0.08% |
20,858
+4,670
| +29% | +$51.9K |
|
|
PVLA
484
Palvella Therapeutics
PVLA
$2.03B
| $186K | 0.08% |
1,244
+1,056
| +562% | +$193K |
|
485
Arbor Realty Trust
ABR
$977M
| $184K | 0.08% |
+14,039
| New | +$225K |
|
486
CytomX Therapeutics
CTMX
$708M
| $184K | 0.08% |
100,604
-17,735
| -15% | -$34K |
|
|
MRNS
487
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $184K | 0.08% |
+37,982
| New | +$231K |
|
488
Sutro Biopharma
STRO
$398M
| $183K | 0.07% |
+3,518
| New | +$197K |
|
|
TRHC
489
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $183K | 0.07% |
71,153
+46,550
| +189% | +$175K |
|
490
Nuvation Bio
NUVB
$2.32B
| $182K | 0.07% |
+56,307
| New | +$246K |
|
491
QuantumScape Corp
QS
$3.19B
| $182K | 0.07% |
21,210
+7,360
| +53% | +$98.3K |
|
492
Gevo
GEVO
$380M
| $181K | 0.07% |
+76,916
| New | +$281K |
|
493
Pacific Biosciences
PACB
$422M
| $181K | 0.07% |
+40,961
| New | +$249K |
|
494
LXP Industrial Trust
LXP
$3.52B
| $180K | 0.07% |
+3,350
| New | +$201K |
|
|
MRSN
495
DELISTED
Mersana Therapeutics
MRSN
| $179K | 0.07% |
1,549
+1,146
| +284% | +$108K |
|
|
CUK
496
DELISTED
Carnival PLC
CUK
| $178K | 0.07% |
+22,500
| New | +$304K |
|
|
VRN
497
DELISTED
Veren
VRN
| $178K | 0.07% |
+24,934
| New | +$196K |
|
498
EVgo
EVGO
$220M
| $177K | 0.07% |
+29,376
| New | +$279K |
|
499
Praxis Precision Medicines
PRAX
$8.8B
| $174K | 0.07% |
+4,746
| New | +$507K |
|
|
RDFN
500
DELISTED
Redfin
RDFN
| $174K | 0.07% |
+21,138
| New | +$242K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2022 Portfolio in Review
As of Q2 2022, XTX Topco held 1,200 positions worth $245M, up 7.3% from $228M the previous quarter. Its ten largest holdings account for 8% of the portfolio.
XTX Topco deployed $61.4M of net new capital in Q2 2022, opening 565 new positions and adding to 162 existing holdings. Its largest new stake was Alphabet (Google) Class A: 38,140 shares worth $4.16M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.65M trimmed.
- XTX Topco's largest Q2 2022 buy was Alphabet (Google) Class A: 38,140 shares worth $4.16M.
- XTX Topco added most to Dow Inc in Q2 2022, an estimated $1.32M increase.
- XTX Topco's biggest Q2 2022 reduction was Johnson & Johnson, cutting an estimated $1.65M.
- XTX Topco fully exited UnitedHealth in Q2 2022, selling an estimated $2.15M.
- XTX Topco's ten largest holdings make up 8% of its $245M portfolio in Q2 2022.
- XTX Topco opened 565 new positions and closed 389 in Q2 2022.
- XTX Topco's portfolio value rose 7.3% quarter-over-quarter to $245M.
Based on XTX Topco's 13F filing for Q2 2022, filed 15 Aug 2022.